|
|
Blood, 15 March 2007, Vol. 109, No. 6, pp. 2496-2504.
Prepublished online as a Blood First Edition Paper on December 5, 2006; DOI 10.1182/blood-2006-07-034231.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
In the absence of IGF-1 signaling, IFN- suppresses human malignant T-cell growth
Laura Conti1,2,
Gabriella Regis1,2,
Angela Longo1,
Paola Bernabei1,
Roberto Chiarle1,
Mirella Giovarelli1,2, and
Francesco Novelli1,2
1 Center for Experimental Research and Medical Studies (CERMS), San Giovanni Battista Hospital, Turin, Italy;
2 Department of Medicine and Experimental Oncology, Section of Pathology, University of Turin, Italy
Several approaches to target insulin-like growth factor-1 (IGF-1) signaling have resulted in the inhibition of the growth of a broad range of tumor cells. Malignant T cells are insensitive to the antiproliferative effects of the interferon- (IFN- )/signal transducer and activator of transcription 1 (STAT1) pathway because of the IGF-1dependent internalization of the IFN- R2 signaling chain. Here we show that human malignant T cells are also resistant to the growth inhibitory effect of both the IGF-1 receptorspecific inhibitor picropodophyllin (PPP) and retrovirus-mediated gene transfer of a dominant negative IGF-1 receptor. However, blockade of IGF-1 receptor perturbs IFN- R2 internalization and induces its cell surface accumulation in malignant T cells. This allows the reinstatement of the IFN- induced STAT1 activation, a high expression of proapoptotic molecules, and the suppression of malignant T-cell growth both in vitro and in vivo in a severe combined immunodeficiency (SCID) mouse model. These data indicate that the inhibition of IGF-1 signaling combined with IFN- administration could be a promising approach to suppress the growth of neoplastic T cells resistant to each treatment on its own.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Vasilcanu, D. Vasilcanu, B. Sehat, S. Yin, A. Girnita, M. Axelson, and L. Girnita
Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin
Mol. Pharmacol.,
March 1, 2008;
73(3):
930 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|